Sort   by:  
 Page size 
UnknownExploring discordant low amyloid beta and high neocortical tau positron emission tomography cases.
Not available
S-EPMC9413469 | biostudies-literature
UnknownLongitudinal exploration of cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma: protocol for a feasibility study.
Not available
S-EPMC7526311 | biostudies-literature
UnknownPlasma high-density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume.
Not available
S-EPMC9804612 | biostudies-literature
UnknownRates of regional tau accumulation in ageing and across the Alzheimer's disease continuum: an AIBL 18F-MK6240 PET study.
Not available
S-EPMC9900352 | biostudies-literature
UnknownRelationship between amyloid and tau levels and its impact on tau spreading.
Not available
S-EPMC8175299 | biostudies-literature
UnknownDiagnostic accuracy of imaging brain vesicular monoamine transporter type 2 (VMAT2) in clinically uncertain parkinsonian syndrome (CUPS): a 3-year follow-up study in community patients.
Not available
S-EPMC6252699 | biostudies-literature
UnknownCancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma undergoing standard chemotherapy: a longitudinal feasibility study.
Not available
S-EPMC9385796 | biostudies-literature
UnknownMesial temporal tau pathology impacts basal forebrain degeneration in early Alzheimer's disease.
Not available
S-EPMC12741919 | biostudies-literature
UnknownCerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individuals.
Not available
S-EPMC9719998 | biostudies-literature
UnknownAmyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's disease.
Not available
S-EPMC12305117 | biostudies-literature
Sort   by:  
 Page size